Weekly Roundup: Amyris sells vitamin E royalties to DSM, DuPont to provide probiotics for infant sepsis research

Related Articles

A girl lies in a pile of books reading books.

NUTRITION & HEALTH NEWS

28 Mar 2024 --- Cognition-boosting ingredients are emerging as a lifespan megatrend as consumers of all ages look to enhance their brain power. Older generations want to... Read More

Four researchers in a lab evaluating the effect of synbiotics.

NUTRITION & HEALTH NEWS

26 Mar 2024 --- New research finds a synergistic effect of a synbiotic by Clasado Biosciences and Probi — combining Clasado’s prebiotic Bimuno GOS... Read More

Researcher in a lab coat looking through a microscope.

NUTRITION & HEALTH NEWS

22 Mar 2024 --- With a heightened interest in gut health, offering F&B products with prebiotic fibers continues to expand. However, Beneo stresses that not all... Read More

Vitafoods promotion at event.

NEW PRODUCT DEVELOPMENT

20 Mar 2024 --- Health and nutrition innovator dsm-firmenich is preparing to debut a “breakthrough” product for the gut health market — Humiome B2,... Read More

A young man sits in front of a computer at his office, pinching between his eyes like he is feeling some stress.

NUTRITION & HEALTH NEWS

15 Mar 2024 --- Novonesis recently achieved a significant milestone with Health Canada’s approval of two health claims for its probiotic strain, Clepius L.... Read More

trans